Merit Medical Systems, Inc. $MMSI Stock Position Raised by Van Hulzen Asset Management LLC

Van Hulzen Asset Management LLC grew its position in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 25.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,877 shares of the medical instruments supplier’s stock after buying an additional 5,778 shares during the quarter. Van Hulzen Asset Management LLC’s holdings in Merit Medical Systems were worth $2,002,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Jupiter Topco LLC bought a new stake in Merit Medical Systems during the second quarter worth approximately $1,908,000. Bessemer Group Inc. boosted its stake in Merit Medical Systems by 54.2% during the 4th quarter. Bessemer Group Inc. now owns 313,981 shares of the medical instruments supplier’s stock valued at $27,674,000 after purchasing an additional 110,392 shares during the period. Trillium Asset Management LLC acquired a new stake in Merit Medical Systems in the 2nd quarter valued at approximately $6,105,000. WINTON GROUP Ltd bought a new position in Merit Medical Systems in the 4th quarter worth approximately $12,239,000. Finally, Quantinno Capital Management LP lifted its holdings in shares of Merit Medical Systems by 200.3% during the first quarter. Quantinno Capital Management LP now owns 17,612 shares of the medical instruments supplier’s stock worth $1,214,000 after buying an additional 11,747 shares during the last quarter. 99.66% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the stock. Barrington Research set a $114.00 target price on shares of Merit Medical Systems in a research report on Friday, July 31st. Wells Fargo & Company boosted their price objective on shares of Merit Medical Systems from $74.00 to $83.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Bank of America lifted their target price on Merit Medical Systems from $92.00 to $97.00 and gave the stock a “neutral” rating in a research report on Thursday, August 13th. JPMorgan Chase & Co. lifted their price target on shares of Merit Medical Systems from $77.00 to $95.00 and gave the stock an “overweight” rating in a research note on Friday, July 31st. Finally, BTIG Research reaffirmed a “buy” rating and set a $105.00 price objective on shares of Merit Medical Systems in a report on Tuesday, August 11th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $100.00.

Merit Medical Systems Stock Down 0.2%

NASDAQ:MMSI opened at $87.19 on Thursday. The company has a current ratio of 4.20, a quick ratio of 2.79 and a debt-to-equity ratio of 0.44. Merit Medical Systems, Inc. has a 1 year low of $59.74 and a 1 year high of $94.75. The stock has a 50-day moving average price of $82.95 and a two-hundred day moving average price of $73.29. The stock has a market cap of $5.21 billion, a price-to-earnings ratio of 36.03, a PEG ratio of 2.18 and a beta of 0.49.

Merit Medical Systems (NASDAQ:MMSI) last released its earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.96 by $0.23. The business had revenue of $418.84 million for the quarter, compared to the consensus estimate of $405.25 million. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.Merit Medical Systems’s quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.01 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. As a group, equities analysts expect that Merit Medical Systems, Inc. will post 3.84 earnings per share for the current year.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.